Onco-Innovations Limited
ONNVF
$2.65
$1.2285.32%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 23.00K | 23.00K | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 23.00K | 23.00K | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | 23.00K | 23.00K | -- | -- | |
| SG&A Expenses | 916.70K | 916.80K | 110.30K | 99.90K | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 982.50K | 982.70K | 132.30K | 118.20K | |
| Operating Income | -959.60K | -959.70K | -132.30K | -118.20K | |
| Income Before Tax | -2.81M | -2.81M | -132.60K | -231.40K | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -2.81M | -2.81M | -132.60K | -231.40K | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -2.81M | -2.81M | -132.60K | -231.40K | |
| EBIT | -959.60K | -959.70K | -132.30K | -118.20K | |
| EBITDA | -- | -- | -- | -- | |
| EPS Basic | -0.08 | -0.08 | 0.00 | -0.01 | |
| Normalized Basic EPS | -0.03 | -0.03 | 0.00 | 0.00 | |
| EPS Diluted | -0.08 | -0.08 | 0.00 | -0.01 | |
| Normalized Diluted EPS | -0.03 | -0.03 | 0.00 | 0.00 | |
| Average Basic Shares Outstanding | 33.91M | 33.91M | 38.39M | 33.91M | |
| Average Diluted Shares Outstanding | 33.91M | 33.91M | 38.39M | 33.91M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |